RxDoctor Payments Data

Ryan Carr, MD

Orthopaedic Surgery · Englewood, CONPI 1700033917

Payments from drug & device makers

What this record shows

This record is dominated by education: $45,094 of the $52,344 with a category attached, or 86.1%. Smith+Nephew accounts for 82.5% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2020 at $24,629 and has fallen 97.3% since, to $661 in 2025.

$52,344in general payments, 2019–2025

Across 61 payments — averaging $858.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$43K
  • Gemini Mountain Medical, LLC$2K
  • Encore Medical, LP$2K
  • Medacta USA, Inc.$1K
  • Stryker$1K
  • Medtronic$840
  • plus $1K from 10 others

What the payments were for

  • Consulting fees$1,8404%
  • Travel & lodging$2,5815%
  • Food & beverage$2,8305%
  • Education$45,09486%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,344 in reported general payments places this provider in the 85th percentile of 383 orthopaedic surgery providers in Colorado.

See all orthopaedic surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$75,768
Medicare patients
101
Services billed
626

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam219$903
Celecoxib23$536
Oxycodone Hcl43$412
Methocarbamol25$376
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$115
Tramadol Hcl18$78

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →